Treatment of Tobacco Use Disorders in Smokers with Serious Mental Illness: Toward Clinical Best Practices
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Addiction to tobacco-derived nicotine remains highly prevalent in the United States, with 18% using daily, and 53% of those with serious mental illness using daily. While smokers with serious mental illness have been excluded from most large nicotine-dependence treatment studies, a growing evidence base is available to guide clinicians in assisting their patients with psychiatric illness to quit smoking. The aim of this review is to present the evidence on safety and efficacy of smoking cessation interventions for those with serious mental illness. Smokers with schizophrenia spectrum disorders should receive varenicline or bupropion with or without nicotine replacement therapy in combination with behavioral treatment. Although more research is needed, preliminary evidence suggests that varenicline in combination with behavioral support is efficacious and well tolerated for smoking cessation for those with bipolar disorder and major depressive disorder. Controlled trials have found no evidence that in patients with serious mental illness, the use of pharmacotherapeutic cessation aids worsens psychiatric symptoms or increases the rate of psychiatric adverse events. Converging evidence indicates that a majority of smokers with serious mental illness want to quit smoking and that available pharmacotherapeutic cessation aids combined with behavioral support are both effective for, and well tolerated by, these smokers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Screening for serious mental illness in the general population
Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., Howes, M. J., Normand, S.-L. T., Manderscheid, R. W., Walters, E. E., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.184 · Cited by 5,692
Actual Causes of Death in the United States, 2000
Mokdad, A. H. (2004) · JAMA · doi:10.1001/jama.291.10.1238 · Cited by 5,211
Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., & Ezzati, M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000058 · Cited by 2,860
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
21st-Century Hazards of Smoking and Benefits of Cessation in the United States
Jha, P., Ramasundarahettige, C., Landsman, V., Rostron, B., Thun, M., Anderson, R. N., McAfee, T., & Peto, R. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1211128 · Cited by 1,767 · cited 1×
“Half of smokers who do not quit will die from a smoking-related illness, and cessation before age 40 nearly eliminates that risk.(14,15) Those with SMI now die approximately 25 years prematurely, largely due to smokingassociated illnesses.”
BackgroundKessler, R. C., Green, J. G., Gruber, M. J., Sampson, N. A., Bromet, E., Cuitan, M., Furukawa, T. A., Gureje, O., Hinkov, H., Hu, C., et al. (2010) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.310 · Cited by 1,434
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087 · cited 1×
“Age-adjustedmortality from smoking-related pulmonary and cardiovascular disease is 2–6 times higher among individuals with schizophrenia than in age-matched samples.(44,45)”
BackgroundPirie, K., Peto, R., Reeves, G. K., Green, J., & Beral, V. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61720-6 · Cited by 799
Cook, B. L., Wayne, G. F., Kafali, E. N., Liu, Z., Shu, C., & Flores, M. (2014) · JAMA · doi:10.1001/jama.2013.284985 · Cited by 519 · cited 1×
“Comparable decreases in smoking rates have not been realized among smokers with psychiatric illness.(3)”
Background
Cited by
Roberts, E., Eden Evins, A., McNeill, A., & Robson, D. (2016) · Addiction · doi:10.1111/add.13236 · Cited by 119
“orwith a primarydiagnosis of alcohol or substance abuse, as those patients are thought to require different treatment needs [32].”
BackgroundKlein, P., Lawn, S., Tsourtos, G., & van Agteren, J. (2019) · JMIR Human Factors · doi:10.2196/14023 · Cited by 35
“Smoking-related studies have revealed that most people with SMI want to quit [8] and often attempt to quit but can find it challenging to quit without support [4,9].”
BackgroundJapuntich, S. J., Hammett, P. J., Rogers, E. S., Fu, S., Burgess, D. J., El Shahawy, O., Melzer, A. C., Noorbaloochi, S., Krebs, P., & Sherman, S. E. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaa013 · Cited by 23
Fortuna, K. L., Lebby, S., Geiger, P., Johnson, D., MacDonald, S., Chefetz, I., Ferron, J. C., St George, L., Rossom, R., Kalisa, J., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.15479 · Cited by 18
“Although most smokers with SMI want to quit 32 and cessation is most likely when both pharmacologic and psychosocial treatment are used, 33 cessation rates are low, and most smokers with SMI relapse months after treatment, 33 suggesting room for improvement in cessation treatments.”
Self-citation
Metadata
- Authors
- Evins, A. E., Cather, C., & Laffer, A.
- Venue
- Harvard Review of Psychiatry
- Published
- 2015-03
- Volume
- 23
- Issue
- 2
- Pages
- 90-98
- ISSN
- 1067-3229 (ISSN-L)
- OpenAlex
- W2045335964
- Cited by
- 85
- References
- 30
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Tobacco Use Disorders in Smokers with Serious Mental Illness: Toward Clinical Best Practices. https://app.cochat.ai/papers/10.1097/hrp.0000000000000063
- The paper
- Evins, A. E., Cather, C., & Laffer, A. (2015). Treatment of Tobacco Use Disorders in Smokers with Serious Mental Illness: Toward Clinical Best Practices. Harvard Review of Psychiatry. https://doi.org/10.1097/hrp.0000000000000063
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.